204 related articles for article (PubMed ID: 19180614)
21. Analysis of von Hippel-Lindau hereditary cancer syndrome: implications of oxygen sensing.
Yang H; Ivan M; Min JH; Kim WY; Kaelin WG
Methods Enzymol; 2004; 381():320-35. PubMed ID: 15063684
[No Abstract] [Full Text] [Related]
22. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
[TBL] [Abstract][Full Text] [Related]
23. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
[TBL] [Abstract][Full Text] [Related]
24. iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells.
Haffey WD; Mikhaylova O; Meller J; Yi Y; Greis KD; Czyzyk-Krzeska MF
Adv Enzyme Regul; 2009; 49(1):121-32. PubMed ID: 19159641
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible factors in the first trimester human lung.
Groenman F; Rutter M; Caniggia I; Tibboel D; Post M
J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520
[TBL] [Abstract][Full Text] [Related]
26. OS-9: another piece in the HIF complex story.
Flashman E; McDonough MA; Schofield CJ
Mol Cell; 2005 Feb; 17(4):472-3. PubMed ID: 15721249
[TBL] [Abstract][Full Text] [Related]
27. Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL.
Xie L; Xiao K; Whalen EJ; Forrester MT; Freeman RS; Fong G; Gygi SP; Lefkowitz RJ; Stamler JS
Sci Signal; 2009 Jul; 2(78):ra33. PubMed ID: 19584355
[TBL] [Abstract][Full Text] [Related]
28. The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress.
Mikhaylova O; Ignacak ML; Barankiewicz TJ; Harbaugh SV; Yi Y; Maxwell PH; Schneider M; Van Geyte K; Carmeliet P; Revelo MP; Wyder M; Greis KD; Meller J; Czyzyk-Krzeska MF
Mol Cell Biol; 2008 Apr; 28(8):2701-17. PubMed ID: 18285459
[TBL] [Abstract][Full Text] [Related]
29. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
[TBL] [Abstract][Full Text] [Related]
30. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.
Minamishima YA; Moslehi J; Padera RF; Bronson RT; Liao R; Kaelin WG
Mol Cell Biol; 2009 Nov; 29(21):5729-41. PubMed ID: 19720742
[TBL] [Abstract][Full Text] [Related]
31. NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species.
Callapina M; Zhou J; Schmid T; Köhl R; Brüne B
Free Radic Biol Med; 2005 Oct; 39(7):925-36. PubMed ID: 16140212
[TBL] [Abstract][Full Text] [Related]
32. HIF prolyl 4-hydroxylases and their potential as drug targets.
Myllyharju J
Curr Pharm Des; 2009; 15(33):3878-85. PubMed ID: 19671043
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.
Pagé EL; Chan DA; Giaccia AJ; Levine M; Richard DE
Mol Biol Cell; 2008 Jan; 19(1):86-94. PubMed ID: 17942596
[TBL] [Abstract][Full Text] [Related]
34. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
Semenza GL
Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
[TBL] [Abstract][Full Text] [Related]
35. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.
Pan Y; Mansfield KD; Bertozzi CC; Rudenko V; Chan DA; Giaccia AJ; Simon MC
Mol Cell Biol; 2007 Feb; 27(3):912-25. PubMed ID: 17101781
[TBL] [Abstract][Full Text] [Related]
36. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
37. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis.
Ginouvès A; Ilc K; Macías N; Pouysségur J; Berra E
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4745-50. PubMed ID: 18347341
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the hypoxia-sensing pathway in Drosophila melanogaster.
Arquier N; Vigne P; Duplan E; Hsu T; Therond PP; Frelin C; D'Angelo G
Biochem J; 2006 Jan; 393(Pt 2):471-80. PubMed ID: 16176182
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
[TBL] [Abstract][Full Text] [Related]
40. The HIF pathway and erythrocytosis.
Lee FS; Percy MJ
Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]